Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Lin H et al. | 1996 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 0.8–80 µT |
| Weisbrot DR et al. | 1993 | intact cell/cell culture, <i>Saccharomyces cerevisiae</i>/S288C; his-, leu- | magnetic field, 50/60 Hz | 0.8–80 µT |
| Yomori H et al. | 2002 | intact cell/cell culture, T98G (human glioblastoma) cells | magnetic field, 50/60 Hz | 1–500 µT |
| Mahaki H et al. | 2019 | animal, rat/Wistar, whole body | 50/60 Hz, magnetic field | 1–2,000 µT |
| Molaei S et al. | 2019 | animal, rat/Wistar albino, whole body | 50/60 Hz, magnetic field | 1–2,000 µT |
| Kanitz MH et al. | 2007 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, 50/60 Hz, electrotherapy, therapeutic/medical device | 1.2 µT |
| Girgert R et al. | 2008 | intact cell/cell culture, MCF-7 (breast cancer cell line, p40 and p181 clone) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
| Girgert R et al. | 2009 | intact cell/cell culture, MCF-7 (breast cancer cell line, p40 and p181 clone) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
| Savage Jr RE et al. | 2005 | intact cell/cell culture, SF767 (human glioma cell line) | magnetic field, low frequency, 50/60 Hz | 1.2 µT |
| Dees C et al. | 1996 | intact cell/cell culture, MCF-7 and T-47D cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz, co-exposure | 1.2–900 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
